These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

311 related articles for article (PubMed ID: 31215490)

  • 21. EGR1 induces tenogenic differentiation of tendon stem cells and promotes rabbit rotator cuff repair.
    Tao X; Liu J; Chen L; Zhou Y; Tang K
    Cell Physiol Biochem; 2015; 35(2):699-709. PubMed ID: 25592085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Physical Microenvironment-Based Inducible Scaffold for Stem Cell Differentiation and Tendon Regeneration.
    Zhang H; Liu MF; Liu RC; Shen WL; Yin Z; Chen X
    Tissue Eng Part B Rev; 2018 Dec; 24(6):443-453. PubMed ID: 29724151
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of autologous bone marrow and adipose tissue derived mesenchymal stem cells, and platelet rich plasma, for treating surgically induced lesions of the equine superficial digital flexor tendon.
    Romero A; Barrachina L; Ranera B; Remacha AR; Moreno B; de Blas I; Sanz A; Vázquez FJ; Vitoria A; Junquera C; Zaragoza P; Rodellar C
    Vet J; 2017 Jun; 224():76-84. PubMed ID: 28697880
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Isolation and implantation of autologous equine mesenchymal stem cells from bone marrow into the superficial digital flexor tendon as a potential novel treatment.
    Smith RK; Korda M; Blunn GW; Goodship AE
    Equine Vet J; 2003 Jan; 35(1):99-102. PubMed ID: 12553472
    [No Abstract]   [Full Text] [Related]  

  • 25. Distribution and persistence of technetium-99 hexamethyl propylene amine oxime-labelled bone marrow-derived mesenchymal stem cells in experimentally induced tendon lesions after intratendinous injection and regional perfusion of the equine distal limb.
    Sole A; Spriet M; Padgett KA; Vaughan B; Galuppo LD; Borjesson DL; Wisner ER; Vidal MA
    Equine Vet J; 2013 Nov; 45(6):726-31. PubMed ID: 23574488
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Physical regulation of stem cells differentiation into teno-lineage: current strategies and future direction.
    Chen JL; Zhang W; Liu ZY; Heng BC; Ouyang HW; Dai XS
    Cell Tissue Res; 2015 May; 360(2):195-207. PubMed ID: 25549759
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplantation of tendon-derived stem cells pre-treated with connective tissue growth factor and ascorbic acid in vitro promoted better tendon repair in a patellar tendon window injury rat model.
    Lui PP; Wong OT; Lee YW
    Cytotherapy; 2016 Jan; 18(1):99-112. PubMed ID: 26719200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mesenchymal stem cell therapy for equine tendinopathy.
    Smith RK
    Disabil Rehabil; 2008; 30(20-22):1752-8. PubMed ID: 18608378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth and Development Symposium: Stem cell therapy in equine tendon injury.
    Reed SA; Leahy ER
    J Anim Sci; 2013 Jan; 91(1):59-65. PubMed ID: 23100589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of recombinant equine growth hormone on the biomechanical properties of healing superficial digital flexor tendons in horses.
    Dowling BA; Dart AJ; Hodgson DR; Rose RJ; Walsh WR
    Vet Surg; 2002; 31(4):320-4. PubMed ID: 12094345
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tenogenic induction of equine mesenchymal stem cells by means of growth factors and low-level laser technology.
    Gomiero C; Bertolutti G; Martinello T; Van Bruaene N; Broeckx SY; Patruno M; Spaas JH
    Vet Res Commun; 2016 Mar; 40(1):39-48. PubMed ID: 26757735
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: A placebo-controlled experimental study.
    Bosch G; van Schie HT; de Groot MW; Cadby JA; van de Lest CH; Barneveld A; van Weeren PR
    J Orthop Res; 2010 Feb; 28(2):211-7. PubMed ID: 19714688
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic strategies for tendon healing based on novel biomaterials, factors and cells.
    Gross G; Hoffmann A
    Pathobiology; 2013; 80(4):203-10. PubMed ID: 23652284
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tenogenically Induced Allogeneic Peripheral Blood Mesenchymal Stem Cells in Allogeneic Platelet-Rich Plasma: 2-Year Follow-up after Tendon or Ligament Treatment in Horses.
    Beerts C; Suls M; Broeckx SY; Seys B; Vandenberghe A; Declercq J; Duchateau L; Vidal MA; Spaas JH
    Front Vet Sci; 2017; 4():158. PubMed ID: 29018808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic adipose tissue-derived mesenchymal stem cells in combination with platelet rich plasma are safe and effective in the therapy of superficial digital flexor tendonitis in the horse.
    Ricco S; Renzi S; Del Bue M; Conti V; Merli E; Ramoni R; Lucarelli E; Gnudi G; Ferrari M; Grolli S
    Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):61-8. PubMed ID: 24046950
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A new clinical approach: use of blood-derived stem cells (BDSCs) for superficial digital flexor tendon injuries in horses.
    Marfe G; Rotta G; De Martino L; Tafani M; Fiorito F; Di Stefano C; Polettini M; Ranalli M; Russo MA; Gambacurta A
    Life Sci; 2012 Jun; 90(21-22):825-30. PubMed ID: 22480518
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Examining the Potential of Vitamin C Supplementation in Tissue-Engineered Equine Superficial Digital Flexor Tendon Constructs.
    Mienaltowski MJ; Callahan M; Gonzales NL; Wong A
    Int J Mol Sci; 2023 Dec; 24(23):. PubMed ID: 38069418
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tendon stem progenitor cells: Understanding the biology to inform therapeutic strategies for tendon repair.
    Walia B; Huang AH
    J Orthop Res; 2019 Jun; 37(6):1270-1280. PubMed ID: 30270569
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transforming Growth Factor Beta 3-Loaded Decellularized Equine Tendon Matrix for Orthopedic Tissue Engineering.
    Roth SP; Brehm W; Groß C; Scheibe P; Schubert S; Burk J
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31684150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In Vitro Comparison of 2D-Cell Culture and 3D-Cell Sheets of Scleraxis-Programmed Bone Marrow Derived Mesenchymal Stem Cells to Primary Tendon Stem/Progenitor Cells for Tendon Repair.
    Hsieh CF; Yan Z; Schumann RG; Milz S; Pfeifer CG; Schieker M; Docheva D
    Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30072668
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.